A recent study published in Engineering has unveiled a novel approach to generating functional organoids from human adult ...

A recent study published in Engineering has shed light on the potential therapeutic effects of dihydrotanshinone I (DHT), a ...

The BioMarin Pharmaceutical Inc. acquisition of Amicus Therapeutics, Inc. will likely be beneficial and accretive for both ...

Immunotherapy has emerged in recent years as a new cancer treatment that is gentler than traditional chemotherapy and causes ...

UCI’s $12M CIRM award for hNSC-01 marks a pivotal shift to clinical-stage development. See how this state-funded "bridge" is ...

From fat cells that stretch like spandex to more flexible muscles, scientists are finding that women’s bodies are just as ...

Contrarius Investment Management, an investment management company, released its third-quarter investor letter for the ...

MIT researchers are using living cells to target diseased brain areas and deliver tiny electronic devices that can modulate ...

Maintaining CDK4/6 inhibition constrains drug‑resistant breast tumors by delaying cell‑cycle entry, and adding CDK2 inhibition further deepens control to guide post‑progression therapy.

It has been claimed that because most of our DNA is active, it must be important, but now human-plant hybrid cells have been ...

Iovance Biotherapeutics targets significant market expansion, with lung cancer representing a $10B U.S. peak sales ...

Understanding how cells decide their fate is a central challenge in biology, complicated by the fact that single-cell RNA ...